Improved outcome of Trypanosoma cruzi infection in rats following treatment in early life with suspensions of heat-killed environmental Actinomycetales

Vaccine

Volumn 25, Issue 17, 2007, Pages 3492-3500

  Fontanella, G H ^a   Pascutti, M F ^a   Daurelio, L ^a   Perez, A R ^a   Nocito, A L ^a   Wojdyla, D ^a   Bottasso, O ^a   Revelli, S S ^a   Stanford, J L ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Actinomycetales; Immunomodulation; Trypanosoma cruzi

Indexed keywords

SODIUM CHLORIDE;

ACTINOMYCETALES; ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC DISEASE; CONTROLLED STUDY; GORDONIA; GORDONIA BRONCHIALIS; IMMUNOTHERAPY; MALE; MYOCARDITIS; NONHUMAN; OUTCOME ASSESSMENT; PARASITEMIA; PRIORITY JOURNAL; RAT; RHODOCOCCUS; RHODOCOCCUS COPROPHILUS; STATISTICAL ANALYSIS; TREATMENT DURATION; TRYPANOSOMA CRUZI;

ACTINOMYCETALES; ANIMALS; ANTIBODIES, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; ENVIRONMENTAL MICROBIOLOGY; IMMUNIZATION; IMMUNOGLOBULIN G; MALE; PARASITEMIA; RATS; SUSPENSIONS;

EID: 34047137281     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.11.062     Document Type: Article

References (33)

1. World Health Organization. Control of Chagas' disease. WHO Technical Report Series 2002;905:109.
2. Brener Z., and Andrade Z. Trypanosoma cruzi e Doença de Chagas (1999), Guanabara Koogan Editorial, Rio de Janeiro
3. Brener Z., and Krettli A.U. Immunology of Chagas' disease. In: Wyler D.J. (Ed). Modern Parasite Biology-Cellular, Immunological and Molecular Aspects (1982), W.H. Freeman and Co., New York 247-261
4. Reed S.G. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J Immunol 140 (1988) 4342-4347
5. Revelli S., Davila H., Ferro M.E., Romero-Piffiguer M., Musso O., Valenti J., et al. Experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon gamma. Microbiol Immunol 39 (1995) 275-282
6. Torrico F., Heremans H., Rivera M.T., Marck E.V., Billiau A., and Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 146 (1991) 3626-3632
7. Prata A. Clinical and epidemiological aspects of Chagas' disease-review. Lancet Infect Dis 1 (2001) 92-100
8. Tanowitz H.B., Kirchhoff L.V., Simon F., Morris S.A., Weiss L.M., and Wittner M. Chagas disease. Clin Microbiol Rev 5 (1992) 400-419
9. Morel C.M., and Lazdins J. Chagas disease. Nat Rev Microbiol 1 (2003) 14-15
10. Rossi M.A., and Ramos S.G. Pathogenesis of chronic Chagas'myocarditis: an overview. Cardiovasc Pathol 5 (1996) 197-202
11. Berra H., Piaggio E., Revelli S., and Luquita A. Blood viscosity changes in experimentally Trypanosoma cruzi-infected rats. Clin Hemorheol Microcirc 32 (2005) 175-182
12. Kalil J., and Cunha-Neto E. Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last?. Parasitol Today 12 (1996) 396-399
13. Girones N., and Fresno M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?. Trends Parasitol 19 (2003) 19-22
14. Leon J.S., and Engman D.M. Autoimmunity in Chagas heart disease. Int J Parasitol 31 (2001) 555-561
15. Tarleton R.L., Zhang L., and Downs M.O. Autoimmune rejection of neonatal heart transplants in experimental Chagas' disease is a parasite-specific response to infected host tissue. Proc Natl Acad Sci USA 94 8 (1997) 3932-3937
16. Arkwright P.D., and David T.J. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 107 (2001) 531-534
17. Zuany-Amorim C., Sawicka E., Manlius C., Le Moine A., Brunet L.R., Kemeny D.M., et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 8 (2002) 625-629
18. Stanford J.L., and Stanford C.A. Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659. Immunobiology 191 (1994) 555-563
19. Dávila H.O., Revelli S., Moreno H.S., Valenti J.L., Musso O.C., Poli H.O., et al. Infection with Trypanosoma cruzi during pregnancy in rats and a decreased in chronic myocardial lesions in their infected offspring. Am J Trop Med Hyg 50 (1994) 506-511
20. Revelli S., Dídoli G., Roggero E., Moreno H., Bernabó J., Wietzerbin J., et al. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma. Cytokines Cell Mol Ther 4 (1998) 153-159
21. Stefani M.M., Takehara H.A., and Mota I. Isotype of antibodies responsible for immune lysis in Trypanosoma cruzi infected mice. Immunol Lett 7 (1983) 91-97
22. Powell M.R., and Wassom D.L. Host genetics and resistance to acute Trypanosoma cruzi infection in mice. I. Antibody isotype profiles. Parasite Immunol 15 (1993) 215-221
23. Rowland E.C., Mikhail K.S., and McCormick T.S. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease. J Parasitol 78 (1992) 557-561
24. El Bouhdidi A., Truyens C., Rivera M.T., Bazin H., and Carlier Y. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunol 16 (1994) 69-76
25. Hughes-Jones N.C., Gorick B.D., and Howard J.C. The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies. Eur J Immunol 13 (1983) 635-641
26. Brüggemann M., Free J., Diamond A., Howard J., Cobbold S., and Waldmann H. Immunoglobulin heavy chain locus of the rat: striking homology to mouse antibody genes. Proc Natl Acad Sci USA 83 (1986) 6075-6079
27. Reis M.M., Higuchi M.L., Benvenuti L.A., Aiello V.D., Gutierrez P.S., Bellotti G., et al. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 83 (1997) 165-172
28. Brener Z., and Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 114 (1997) 103-110
29. Higuchi M.L., De Morais F., Pereira-Barreto A.C., Lopes E.A., Stolf N., Bellotti G., et al. The role of active myocarditis in the development of heart failure in chronic Chagas disease: a study based on endomyocardial biopsies. Clin Cardiol 10 (1987) 665-670
30. Pontes-De-Carvalho L., Santana C.C., Soares M.B., Oliveira G.G., Cunha-Neto E., and Ribeiro-Dos-Santos R. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmun 18 (2002) 131-138
31. Reis D.A., Jones E.M., Tostes S., Lopes E.R., Chapadeiro E., Gazzinelli G., et al. Expression of major histcompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas'disease. Am J Trop Med Hyg 49 (1993) 192-200
32. Zhang L., and Tarleton R.L. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol 26 (1996) 102-109
33. Dias J.C. The indeterminate form of human chronic Chagas'disease, a clinical epidemiological review. Rev Soc Bras Med Trop 22 (1989) 147-156